Novel mechanism-based therapeutics for androgen axis blockade in castration-resistant prostate cancer

Keyphrases

• Castration-resistant Prostate Cancer 100%
• Novel Mechanism 100%
• Mechanism-based 100%
• Androgen Axis 100%
• Bromodomain 66%
• Mechanism of Action 66%
• Clinical Development 66%
• Unique Mechanism 66%
• Androgen Receptor 33%
• Novel Therapeutics 33%
• Prostate Cancer 33%
• Treatment Options 33%
• Androgen Signaling 33%
• Precision Medicine 33%
• Novel Therapies 33%
• Enzalutamide 33%
• Molecular Alterations 33%
• Abiraterone 33%
• Splice Variant 33%
• Resistance Mechanisms 33%
• Variant Forms 33%
• Cytochrome 33%
• Novel Agents 33%
• Androgen Receptor Antagonist 33%
• Degrader 33%
• Unique Characteristics 33%
• Constitutively Active 33%
• Activating Receptors 33%
• Chromatin Binding 33%
• Drugs in Development 33%
• 17,20-Lyase 33%
• Cancer Progress 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Castration Resistant Prostate Cancer 100%
• Androgen 100%
• Enzalutamide 25%
• Prostate Cancer 25%
• Androgen Receptor 25%
• Receptor 25%
• Abiraterone 25%
• Steroid 17alpha Monooxygenase 25%
• Androgen Receptor Antagonist 25%
• Cytochrome 25%
• Diseases 25%